Anaptysbio, Inc
ANAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001370053
No open-market purchases or sales by Anaptysbio, Inc insiders were filed in the last 90 days; 213 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Anaptysbio, Inc as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 160
- +27 vs. Q2 2024
- Shares held
- 33.6M
- +5.67M (+20.3%) vs. Q2 2024
- Total value
- $1.13B
- +$426.4M (+60.9%) vs. Q2 2024
- New holders
- 38
- 61 more added
- Sold out
- 11
- 31 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 213 | $2.03B |
| Q1 2026 | 208 | $1.55B |
| Q4 2025 | 179 | $1.42B |
| Q3 2025 | 166 | $980.2M |
| Q2 2025 | 148 | $816.2M |
| Q1 2025 | 153 | $742.8M |
| Q4 2024 | 136 | $468.9M |
| Q3 2024 | 160 | $1.13B |
| Q2 2024 | 135 | $746.6M |
| Q1 2024 | 133 | $658.1M |
| Q4 2023 | 119 | $646.4M |
| Q3 2023 | 116 | $544.5M |
| Q2 2023 | 116 | $614.9M |
| Q1 2023 | 113 | $675.4M |
| Q4 2022 | 118 | $1.02B |
| Q3 2022 | 114 | $830.6M |
| Q2 2022 | 124 | $632.6M |
| Q1 2022 | 131 | $735.4M |
| Q4 2021 | 136 | $964.4M |
| Q3 2021 | 127 | $748.8M |
| Q2 2021 | 122 | $720.6M |
| Q1 2021 | 122 | $628.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Anaptysbio, Inc; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Squarepoint Ops LLC | 44,505 | $1.49M | 0.00% | +33,320+297.9% | Added |
| Jacobs Levy Equity Management, Inc | 46,074 | $1.54M | 0.01% | −1,129−2.4% | Reduced |
| AQR Capital Management LLC | 48,592 | $1.63M | 0.00% | +48,592 | New |
| UBS Oconnor LLC | 50,588 | $1.69M | 0.04% | −29,256−36.6% | Reduced |
| Invesco Ltd. | 51,290 | $1.72M | 0.00% | +32,380+171.2% | Added |
| Qube Research & Technologies Ltd | 53,028 | $1.78M | 0.00% | +53,028 | New |
| Jane Street Group, LLC | 53,157 | $1.78M | 0.00% | +9,795+22.6% | Added |
| Point72 Asset Management, L.P. | 54,200 | $1.82M | 0.01% | +36,300+202.8% | Added |
| Nuveen Asset Management, LLC | 56,012 | $1.88M | 0.00% | 00.0% | Unchanged |
| TD Asset Management Inc | 62,000 | $1.98M | 0.00% | +24,200+64.0% | Added |
| Bank of New York Mellon Corp | 59,141 | $1.98M | 0.00% | −15,369−20.6% | Reduced |
| Fisher Asset Management, LLC | 61,948 | $2.08M | 0.00% | −3,044−4.7% | Reduced |
| Wellington Management Group LLP | 65,939 | $2.21M | 0.00% | +3,048+4.8% | Added |
| BNP Paribas Arbitrage, SA | 66,109 | $2.21M | 0.00% | +65,027+6,009.9% | Added |
| Platinum Investment Management Ltd | 75,292 | $2.52M | 0.11% | −7,109−8.6% | Reduced |
| Ensign Peak Advisors, Inc | 75,755 | $2.54M | 0.00% | 00.0% | Unchanged |
| Neuberger Berman Group LLC | 79,535 | $2.66M | 0.00% | +79,535 | New |
| Macquarie Group Ltd | 93,732 | $3.14M | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 95,972 | $3.22M | 0.00% | −239,962−71.4% | Reduced |
| Trexquant Investment LP | 97,872 | $3.28M | 0.04% | +71,158+266.4% | Added |
| Parkman Healthcare Partners LLC | 138,100 | $4.63M | 0.59% | −118,207−46.1% | Reduced |
| Cubist Systematic Strategies, LLC | 155,107 | $5.20M | 0.08% | +100,834+185.8% | Added |
| Charles Schwab Investment Management Inc | 160,321 | $5.37M | 0.00% | +5,043+3.2% | Added |
| Walleye Capital LLC | 163,997 | $5.49M | 0.06% | +163,997 | New |
| Bank of America Corp | 166,236 | $5.57M | 0.00% | +62,235+59.8% | Added |
| Voloridge Investment Management, LLC | 173,221 | $5.80M | 0.02% | +173,221 | New |
| Morgan Stanley | 177,382 | $5.94M | 0.00% | +85,614+93.3% | Added |
| Farallon Capital Management, L.L.C. | 183,876 | $6.16M | 0.03% | +183,876 | New |
| Two Sigma Advisers, LP | 185,500 | $6.21M | 0.01% | +63,100+51.6% | Added |
| ADAR1 Capital Management, LLC | 192,720 | $6.46M | 1.08% | +36,921+23.7% | Added |
| Northern Trust Corp | 199,913 | $6.70M | 0.00% | +5,788+3.0% | Added |
| Renaissance Technologies LLC | 200,400 | $6.71M | 0.01% | +47,698+31.2% | Added |
| Citadel Advisors LLC | 205,545 | $6.89M | 0.01% | +124,564+153.8% | Added |
| Two Sigma Investments, LP | 211,577 | $7.09M | 0.02% | +71,076+50.6% | Added |
| D. E. Shaw & Co., Inc. | 224,137 | $7.51M | 0.01% | +52,687+30.7% | Added |
| Victory Capital Management Inc | 237,250 | $7.95M | 0.01% | +206,750+677.9% | Added |
| Eventide Asset Management, LLC | 263,748 | $8.84M | 0.15% | −304,576−53.6% | Reduced |
| Jennison Associates LLC | 264,889 | $8.87M | 0.01% | +264,889 | New |
| Balyasny Asset Management LLC | 303,211 | $10.2M | 0.03% | +303,211 | New |
| Federated Hermes, Inc. | 317,243 | $10.6M | 0.02% | +281,186+779.8% | Added |
| Millennium Management LLC | 331,566 | $11.1M | 0.01% | −42,196−11.3% | Reduced |
| Cormorant Asset Management, LP | 342,465 | $11.5M | 0.61% | +342,465 | New |
| Goldman Sachs Group Inc | 350,364 | $11.7M | 0.00% | +155,825+80.1% | Added |
| 5AM Venture Management, LLC | 357,733 | $12.0M | 2.48% | 00.0% | Unchanged |
| Franklin Resources Inc | 354,370 | $12.3M | 0.00% | −111,003−23.9% | Reduced |
| Woodline Partners LP | 459,979 | $15.4M | 0.13% | +207,613+82.3% | Added |
| Geode Capital Management, LLC | 465,401 | $15.6M | 0.00% | +13,336+3.0% | Added |
| Assenagon Asset Management S.A. | 475,446 | $15.9M | 0.03% | +168,813+55.1% | Added |
| Mangrove Partners | 689,521 | $23.1M | 2.23% | 00.0% | Unchanged |
| Palo Alto Investors LP | 843,971 | $28.3M | 3.67% | +40,330+5.0% | Added |
| State Street Corp | 906,182 | $30.4M | 0.00% | −60,670−6.3% | Reduced |
| Price T Rowe Associates Inc | 923,117 | $30.9M | 0.00% | +622,893+207.5% | Added |
| First Light Asset Management, LLC | 948,131 | $31.8M | 2.64% | +168,973+21.7% | Added |
| Boxer Capital, LLC | 1,300,000 | $43.5M | 2.14% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,330,879 | $44.6M | 3.18% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,700,156 | $57.0M | 0.00% | +275,750+19.4% | Added |
| BlackRock, Inc. | 2,180,189 | $73.0M | 0.00% | +2,180,189 | New |
| Frazier Life Sciences Management, L.P. | 2,209,189 | $74.0M | 2.97% | +43,598+2.0% | Added |
| FMR LLC | 3,309,175 | $110.9M | 0.01% | +438,557+15.3% | Added |
| EcoR1 Capital, LLC | 7,794,996 | $261.1M | 8.95% | +273,972+3.6% | Added |
| Camber Capital Management LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −249,609−100.0% | Sold out |
| Nordea Investment Management AB | 0 | $0 | 0.00% | −135,614−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −20,455−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −10,178−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −2,390−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −714−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −283−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |